8
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Prostaglandin profiling reveals a role for haematopoietic prostaglandin D synthase in adipose tissue macrophage polarisation in mice and humans

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background/Objectives

          Obesity has been associated with both changes in adipose tissue lipid metabolism and inflammation. A key class of lipid-derived signalling molecules involved in inflammation are the prostaglandins. In this study we aimed to determine how obesity affects the levels of prostaglandins within white adipose tissue and determine which cells within adipose tissue produce them. To avoid the effects of cellular stress on prostaglandin levels we developed a multivariate-statistical approach in which metabolite concentrations and transcriptomic data were integrated, allowing the assignment of metabolites to cell types.

          Subjects/Methods

          Eicosanoids were measured by LC-MS/MS and mRNA levels using real-time PCR. Eicosanoid levels and transcriptomic data were combined using Principal Component Analysis and Hierarchical Clustering in order to associate metabolites with cell types. Samples were obtained from C57Bl/6 mice of 16 weeks of age. We studied the ob/ob genetically obese mouse model and diet induced obesity model. We extended our results in mice to a cohort of morbidly obese humans undergoing bariatric surgery.

          Results

          Using our modelling approach we determined that PGD 2 in adipose tissue was predominantly produced in macrophages by the haematopoietic isoform of prostaglandin D synthase ( H-Pgds). Analysis of sub-fractionated WAT confirmed that H-Pgds was expressed in adipose tissue macrophages (ATM). Furthermore, H-Pgds expression in ATMs isolated from lean and obese mice was consistent with it affecting macrophage polarisation. Functionally, we demonstrated that H-PGDS-produced PGD 2 polarised macrophages toward an M2, anti-inflammatory state. In line with a potential anti-inflammatory role, we found that H-PGDS expression in ATMs was positively correlated with both peripheral insulin and adipose tissue insulin sensitivity in humans.

          Conclusions

          In this study we have developed a method to determine the cellular source of metabolites within an organ and used it to identify a new role for PGD 2 in the control of ATM polarisation.

          Related collections

          Most cited references33

          • Record: found
          • Abstract: found
          • Article: not found

          Macrophage-specific PPARgamma controls alternative activation and improves insulin resistance.

          Obesity and insulin resistance, the cardinal features of metabolic syndrome, are closely associated with a state of low-grade inflammation. In adipose tissue chronic overnutrition leads to macrophage infiltration, resulting in local inflammation that potentiates insulin resistance. For instance, transgenic expression of Mcp1 (also known as chemokine ligand 2, Ccl2) in adipose tissue increases macrophage infiltration, inflammation and insulin resistance. Conversely, disruption of Mcp1 or its receptor Ccr2 impairs migration of macrophages into adipose tissue, thereby lowering adipose tissue inflammation and improving insulin sensitivity. These findings together suggest a correlation between macrophage content in adipose tissue and insulin resistance. However, resident macrophages in tissues display tremendous heterogeneity in their activities and functions, primarily reflecting their local metabolic and immune microenvironment. While Mcp1 directs recruitment of pro-inflammatory classically activated macrophages to sites of tissue damage, resident macrophages, such as those present in the adipose tissue of lean mice, display the alternatively activated phenotype. Despite their higher capacity to repair tissue, the precise role of alternatively activated macrophages in obesity-induced insulin resistance remains unknown. Using mice with macrophage-specific deletion of the peroxisome proliferator activated receptor-gamma (PPARgamma), we show here that PPARgamma is required for maturation of alternatively activated macrophages. Disruption of PPARgamma in myeloid cells impairs alternative macrophage activation, and predisposes these animals to development of diet-induced obesity, insulin resistance, and glucose intolerance. Furthermore, gene expression profiling revealed that downregulation of oxidative phosphorylation gene expression in skeletal muscle and liver leads to decreased insulin sensitivity in these tissues. Together, our findings suggest that resident alternatively activated macrophages have a beneficial role in regulating nutrient homeostasis and suggest that macrophage polarization towards the alternative state might be a useful strategy for treating type 2 diabetes.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Fetuin-A acts as an endogenous ligand of TLR4 to promote lipid-induced insulin resistance.

            Toll-like receptor 4 (TLR4) has a key role in innate immunity by activating an inflammatory signaling pathway. Free fatty acids (FFAs) stimulate adipose tissue inflammation through the TLR4 pathway, resulting in insulin resistance. However, current evidence suggests that FFAs do not directly bind to TLR4, but an endogenous ligand for TLR4 remains to be identified. Here we show that fetuin-A (FetA) could be this endogenous ligand and that it has a crucial role in regulating insulin sensitivity via Tlr4 signaling in mice. FetA (officially known as Ahsg) knockdown in mice with insulin resistance caused by a high-fat diet (HFD) resulted in downregulation of Tlr4-mediated inflammatory signaling in adipose tissue, whereas selective administration of FetA induced inflammatory signaling and insulin resistance. FFA-induced proinflammatory cytokine expression in adipocytes occurred only in the presence of both FetA and Tlr4; removing either of them prevented FFA-induced insulin resistance. We further found that FetA, through its terminal galactoside moiety, directly binds the residues of Leu100-Gly123 and Thr493-Thr516 in Tlr4. FFAs did not produce insulin resistance in adipocytes with mutated Tlr4 or galactoside-cleaved FetA. Taken together, our results suggest that FetA fulfills the requirement of an endogenous ligand for TLR4 through which lipids induce insulin resistance. This may position FetA as a new therapeutic target for managing insulin resistance and type 2 diabetes.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Adipose tissue expandability, lipotoxicity and the Metabolic Syndrome--an allostatic perspective.

              While the link between obesity and type 2 diabetes is clear on an epidemiological level, the underlying mechanism linking these two common disorders is not as clearly understood. One hypothesis linking obesity to type 2 diabetes is the adipose tissue expandability hypothesis. The adipose tissue expandability hypothesis states that a failure in the capacity for adipose tissue expansion, rather than obesity per se is the key factor linking positive energy balance and type 2 diabetes. All individuals possess a maximum capacity for adipose expansion which is determined by both genetic and environmental factors. Once the adipose tissue expansion limit is reached, adipose tissue ceases to store energy efficiently and lipids begin to accumulate in other tissues. Ectopic lipid accumulation in non-adipocyte cells causes lipotoxic insults including insulin resistance, apoptosis and inflammation. This article discusses the links between adipokines, inflammation, adipose tissue expandability and lipotoxicity. Finally, we will discuss how considering the concept of allostasis may enable a better understanding of how diabetes develops and allow the rational design of new anti diabetic treatments. Copyright (c) 2009 Elsevier B.V. All rights reserved.
                Bookmark

                Author and article information

                Journal
                101256108
                32579
                Int J Obes (Lond)
                Int J Obes (Lond)
                International journal of obesity (2005)
                0307-0565
                1476-5497
                17 January 2015
                24 March 2015
                July 2015
                01 January 2016
                : 39
                : 7
                : 1151-1160
                Affiliations
                [1 ]University of Cambridge Metabolic Research Laboratories, Wellcome Trust-MRC Institute of Metabolic Science Cambridge, United Kingdom
                [2 ]Medical Research Council Human Nutrition Research, Cambridge, United Kingdom
                [3 ]Nestlé Institute of Health Sciences, Lausanne, Switzerland
                [4 ]Department of Endocrinology and Metabolism, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands
                [5 ]Department of Medical Biochemistry, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands
                [6 ]The Department of Biochemistry, Tennis Court Road, Cambridge, United Kingdom
                [7 ]Metabolomx,, Mountain View, California, United States
                Author notes
                For offprint requests please contact: Sam Virtue, University of Cambridge Metabolic Research Laboratories, Wellcome Trust-MRC Institute of Metabolic Science Cambridge, United Kingdom, CB2 0QQ. Tel: 01223336786 Fax: +44 1223 R330598
                [# ]Corresponding authors: Mojgan Masoodi Mojgan.Masoodi@ 123456rd.nestle.com and Sam Virtue sv234@ 123456medschl.cam.ac.uk
                Article
                EMS61661
                10.1038/ijo.2015.34
                4486370
                25801691
                541ae941-1d5d-4578-ac30-18ea2b03b745
                History
                Categories
                Article

                Nutrition & Dietetics
                Nutrition & Dietetics

                Comments

                Comment on this article